Cellular Therapies in Pediatric Liver Diseases
Liver transplantation is the gold standard for the treatment of pediatric end-stage liver disease and liver based metabolic disorders. Although liver transplant is successful, its wider application is limited by shortage of donor organs, surgical complications, need for life long immunosuppressive m...
Main Authors: | Sunitha Vimalesvaran, Jessica Nulty, Anil Dhawan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/16/2483 |
Similar Items
-
Prognostic Markers in Pediatric Acute Liver Failure
by: Andreia Filipa Nogueira, et al.
Published: (2023-07-01) -
Liver transplantation in children: the experience of last decades, current problems and solutions
by: N. D. Ventslovayte, et al.
Published: (2020-06-01) -
The perspectives of autologous hepatocytes generation for the treatment of liver failure
by: M. N. Evseeva, et al.
Published: (2015-12-01) -
Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure
by: Cheng-Maw Ho, et al.
Published: (2020-06-01) -
TRANSPLANTATION OF HEPATOCYTES AS THE METHOD OF TREATMENT OF LIVER FAILURE: EXPERIMENTAL AND CLINICAL EXPERIENCE
by: M. Y. Shagidulin, et al.
Published: (2010-06-01)